Garden announced BLOOM (Branching Lookup Optimized for Organic Molecules), a Markush structure search engine that gives AI drug-design teams near-instant verification of small-molecule IP landscapes, so researchers can iterate on candidates with legal certainty built into the loop. As AI models generate molecules faster than ever, the bottleneck has become...
Tahoe Therapeutics announced $30 million in new funding to build the definitive foundational dataset for training Virtual Cell Models. With this, the team will generate one billion single-cell datapoints, mapping one million drug-patient interactions, a scale previously impossible. The dataset will support the discovery of new precision medicines for...
HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, has announced the launch of FibroSIGHT™ Plus, its second Laboratory Developed Test (LDT) available in the United States. Building on the foundation of FibroSIGHT™, which debuted just months earlier, FibroSIGHT™ Plus introduces an additional feature of automated quantitative analysis of...
Here is AITech365’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the nuances that follow the news.
In Automation in AI news this week…
AI Humanoid Robot Deployed by Realbotix at Tix4 in Las Vegas
Realbotix, a leader in AI-powered humanoid...
Phone-based AI assistant generates complete progress notes from 30-45 second voice interactions, reducing documentation time by 50%
Pieces Technologies Inc., a pioneer in healthcare artificial intelligence, announced the launch of "Pieces in your Pocket", an advanced phone-based personal assistant for inpatient physicians that revolutionizes clinical documentation. Using their mobile device,...
August Health is proud to announce $29 million in Series B funding, led by Base10 Partners, to further August Health’s mission to empower the essential work of caring for our elders. Existing investors General Catalyst and Matrix Partners are participating in the round, along with new strategic partners Equitage Ventures,...
Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases.
XtalPi, a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced a transformative strategic collaboration with DoveTree Medicines, a biotechnology pioneer founded by renowned drug...
Lane to lead product and engineering strategy, driving innovation and growth in AI-powered real-world evidence and outcomes solutions for healthcare
OM1, the leader in real-world evidence (RWE) generation and AI-driven insights for healthcare and life sciences, announced the appointment of Hunter Lane as Chief Product Officer. In this role, Lane...
Turbine, a leading developer of cell simulations with AI, announced a research collaboration with MSD (the tradename of Merck & Co., Inc., Rahway NJ USA) to create simulations of cancer patient populations that remain difficult to treat and study in laboratory settings.
To develop novel treatments for patients, scientists must...
BioDuro, a globally trusted Contract Research, Development, and Manufacturing Organization (CRDMO), and Atombeat Inc., a leading force in AI for drug discovery, announced a strategic collaboration to an AI powered platform for accelerated peptide drug discovery.
This collaboration brings together Atombeat’s in silico modeling expertise, AI-accelerated & data-driven design platform...
